These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24147998)

  • 1. Overexpression of melanoma-associated antigen D4 is an independent prognostic factor in squamous cell carcinoma of the esophagus.
    Oya H; Kanda M; Takami H; Hibino S; Shimizu D; Niwa Y; Koike M; Nomoto S; Yamada S; Nishikawa Y; Asai M; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Kodera Y
    Dis Esophagus; 2015; 28(2):188-95. PubMed ID: 24147998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of serum melanoma-associated antigen D4 in patients with squamous cell carcinoma of the esophagus.
    Oya H; Kanda M; Koike M; Iwata N; Niwa Y; Shimizu D; Takami H; Sueoka S; Hashimoto R; Ezaka K; Nomoto S; Yamada S; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Kodera Y
    Dis Esophagus; 2016 Aug; 29(6):663-9. PubMed ID: 25951896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression, Function, and Prognostic Value of MAGE-D4 Protein in Esophageal Squamous Cell Carcinoma.
    Uno Y; Kanda M; Sato Y; Shimizu D; Umeda S; Hattori N; Hayashi M; Tanaka C; Kobayashi D; Yamada S; Nakayama G; Motoyama S; Koike M; Kodera Y
    Anticancer Res; 2019 Nov; 39(11):6015-6023. PubMed ID: 31704827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of MAGE-D4 expression in hepatocellular carcinoma in Japanese patients.
    Takami H; Kanda M; Oya H; Hibino S; Sugimoto H; Suenaga M; Yamada S; Nishikawa Y; Asai M; Fujii T; Nomoto S; Kodera Y
    J Surg Oncol; 2013 Dec; 108(8):557-62. PubMed ID: 24068544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Significance of MAGE-A11 in Esophageal Squamous Cell Carcinoma and Identification of Related Genes Based on DNA Microarray.
    Sang M; Gu L; Liu F; Lian Y; Yin D; Fan X; Ding C; Huang W; Liu S; Shan B
    Arch Med Res; 2016 Apr; 47(3):151-61. PubMed ID: 27362547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus.
    Hibino S; Kanda M; Oya H; Takami H; Shimizu D; Nomoto S; Hishida M; Niwa Y; Koike M; Yamada S; Nishikawa Y; Asai M; Nakayama G; Fujii T; Sugimoto H; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Feb; 31(2):693-700. PubMed ID: 24317529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between the high expression levels of cancer-germline genes with clinical characteristics in esophageal squamous cell carcinoma.
    Chen X; Wang L; Yue D; Liu J; Huang L; Yang L; Cao L; Qin G; Li A; Wang D; Wang M; Qi Y; Zhang B; van der Bruggen P; Zhang Y
    Histol Histopathol; 2017 Aug; 32(8):793-803. PubMed ID: 27868181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stathmin is a marker of progression and poor prognosis in esophageal carcinoma.
    Wang F; Xuan XY; Yang X; Cao L; Pang LN; Zhou R; Fan QX; Wang LX
    Asian Pac J Cancer Prev; 2014; 15(8):3613-8. PubMed ID: 24870766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression.
    Kanda M; Nomoto S; Oya H; Takami H; Shimizu D; Hibino S; Hashimoto R; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S214-21. PubMed ID: 25743330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta binding receptor endoglin (CD105) expression in esophageal cancer and in adjacent nontumorous esophagus as prognostic predictor of recurrence.
    Bellone G; Solerio D; Chiusa L; Brondino G; Carbone A; Prati A; Scirelli T; Camandona M; Palestro G; Dei Poli M
    Ann Surg Oncol; 2007 Nov; 14(11):3232-42. PubMed ID: 17682823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-testis gene expression profiling in esophageal squamous cell carcinoma: identification of specific tumor marker and potential targets for immunotherapy.
    Forghanifard MM; Gholamin M; Farshchian M; Moaven O; Memar B; Forghani MN; Dadkhah E; Naseh H; Moghbeli M; Raeisossadati R; Abbaszadegan MR
    Cancer Biol Ther; 2011 Aug; 12(3):191-7. PubMed ID: 21613820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of MAGE-D4 in colorectal cancer is a potentially prognostic biomarker and immunotherapy target.
    Zhang QM; He SJ; Shen N; Luo B; Fan R; Fu J; Luo GR; Zhou SF; Xiao SW; Xie XX
    Int J Clin Exp Pathol; 2014; 7(7):3918-27. PubMed ID: 25120768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpressed PTOV1 associates with tumorigenesis and progression of esophageal squamous cell carcinoma.
    Li R; Leng AM; Liu XM; Hu TZ; Zhang LF; Li M; Jiang XX; Zhou YW; Xu CX
    Tumour Biol; 2017 Jun; 39(6):1010428317705013. PubMed ID: 28651486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase D1 mRNA level may predict cancer-specific survival in heavy smokers with esophageal squamous cell cancers.
    Xie X; Zhang SS; Wen J; Yang H; Luo KJ; Yang F; Hu Y; Fu JH
    Dis Esophagus; 2014; 27(2):188-95. PubMed ID: 23621299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
    He Z; Yi J; Jin L; Pan B; Chen L; Song H
    Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of MAGE-D4, a novel MAGE family antigen, is correlated with tumor-cell proliferation of non-small cell lung cancer.
    Ito S; Kawano Y; Katakura H; Takenaka K; Adachi M; Sasaki M; Shimizu K; Ikenaka K; Wada H; Tanaka F
    Lung Cancer; 2006 Jan; 51(1):79-88. PubMed ID: 16225959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition.
    Lee KW; Kim JH; Han S; Sung CO; Do IG; Ko YH; Um SH; Kim SH
    Ann Surg Oncol; 2012 Jan; 19(1):326-35. PubMed ID: 21732143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAGE, BAGE, and GAGE gene expression in patients with esophageal squamous cell carcinoma and adenocarcinoma of the gastric cardia.
    Zambon A; Mandruzzato S; Parenti A; Macino B; Dalerba P; Ruol A; Merigliano S; Zaninotto G; Zanovello P
    Cancer; 2001 May; 91(10):1882-8. PubMed ID: 11346870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathological and prognostic significance of the expression of ADAM17 mRNA and protein in esophageal squamous cell carcinoma].
    Liu HB; Yang QC; Shen Y; Zhu Y; Zhang XJ; Chen H
    Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):361-5. PubMed ID: 24054013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demethylation-mediated upregulation of melanoma-associated antigen-A11 correlates with malignant progression of esophageal squamous cell carcinoma.
    Gu L; Sang M; Li J; Liu F; Wu Y; Liu S; Shan B
    Dig Liver Dis; 2019 Oct; 51(10):1475-1482. PubMed ID: 31155488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.